Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Scribed by Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; Eric A. Strom; Laura Guerra; Shu-Wan Kau; Ana M. Gonzalez-Angulo; Gabriel N. Hortobagyi; Vicente Valero

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 199 KB
• Volume: 116
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.24901